We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6770:TWSEPowerchip Semiconductor Manufacturing Corp. Analysis

Data as of 2026-03-11 - not real-time

NT$66.30

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Powerchip’s stock is trading at TWD 66.3, comfortably above its 20‑day (66.03) and 50‑day (56.91) moving averages, indicating short‑term bullish momentum, while the RSI of 53 suggests no immediate overbought condition. The MACD, however, has turned bearish with a negative histogram, hinting at possible downside pressure near the resistance level of TWD 78.9. Market sentiment is extremely greedy (Fear‑Greed Index 76.09), which may be inflating the price despite underlying weaknesses.
Fundamentally, the company shows 12% revenue growth but remains loss‑making with negative gross (‑3.3%) and operating margins (‑4.9%) and a trailing EPS of –1.86. Debt is high at TWD 66.9 bn, yielding a debt‑to‑equity of 81.6%, while cash balances (TWD 25.9 bn) are insufficient to cover liabilities, resulting in negative free cash flow. The forward EPS of 1.99 translates to a forward P/E of 33.3, slightly below the industry average of 36.8, yet the DCF‑derived fair value of TWD 20.5 is far beneath the current price, flagging substantial overvaluation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above 20‑day and 50‑day SMAs
  • Extreme greed sentiment boosting demand
  • Bearish MACD indicating possible near‑term pullback

Medium Term

1–3 years
Cautious
Model confidence: 5/10

Key Factors

  • Significant overvaluation versus DCF fair value
  • Negative profit margins and free cash flow
  • High leverage with debt‑to‑equity above 80%

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Structural debt burden limiting financial flexibility
  • Cyclical semiconductor sector exposure
  • Lack of dividend and uncertain cash‑generation outlook

Key Metrics & Analysis

Financial Health

Revenue Growth12.30%
Profit Margin-16.72%
P/E Ratio33.3
ROE-9.16%
ROA-2.00%
Debt/Equity81.62
P/B Ratio3.4
Op. Cash FlowNT$7.8B
Free Cash FlowNT$-5897912832
Industry P/E36.8

Technical Analysis

TrendBullish
RSI53.6
SupportNT$57.90
ResistanceNT$78.90
MA 20NT$66.03
MA 50NT$56.91
MA 200NT$30.67
MACDBearish
VolumeStable
Fear & Greed Index76.09

Valuation

Fair ValueNT$20.48
Target PriceNT$61.94
Upside/Downside-6.58%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.75
Volatility102.30%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.